Hemodialysis Patients May Benefit from Cholecalciferol Treatment Targeting High Level of 25(OH)D

Hemodialysis Patients May Benefit from Cholecalciferol Treatment Targeting High Level of 25(OH)D

(1) <i>Background and Objectives</i>: Vitamin D is implicated in the pathogenesis of Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD) in hemodialysis (HD) patients, including the development of secondary hyperparathyroidism (SHP). While cholecalciferol supplementation is recomm...

Full description

Bibliographic Details
Main Authors: Agnieszka Tarasewicz, Małgorzata Dąbrowska, Michał Komorniczak, Agnieszka Zakrzewska, Bogdan Biedunkiewicz, Sylwia Małgorzewicz, Magdalena Jankowska, Katarzyna Jasiulewicz, Natalia Płonka, Alicja Dębska-Ślizień, Leszek Tylicki
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
cholecalciferol
chronic kidney disease–mineral and bone disorder
hemodialysis
parathormone
vitamin D
25-hydroxycholecalciferol
Online Access:https://www.mdpi.com/1648-9144/60/11/1831

Internet

https://www.mdpi.com/1648-9144/60/11/1831

Similar Items